Johnson County Clin Trials

A Double-Blinded, Placebo-controlled, Double Dummy, Multi-center Randomized, Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on One to Three Glucose-lowering Agent.

A seamless Phase 1/2, observer-blind, randomized, placebo-controlled, multicenter study to assess the safety and immunogenicity of a UTI vaccine when administered to adults 18 through 64 years of age and clinical efficacy when administered to females 18 through 64 years of age.

A Phase 1, single center, open label, single dose, dose escalation study to determine the safety and immunogenicity of a novel bivalent norovirus G1.1 and G2.4 vaccine administered orally to healthy volunteers aged ≥18 years and ≤80 years old.

A two-stage, randomized, double-blind, dose ranging phase 2 trial in healthy adult participants to investigate optimal dose and dosing regimen, and to evaluate safety and immunogenicity of the recombinant MVA‑BN‑WEV vaccine.

A Phase 2, Randomized, Observer-blind Study to Evaluate the Safety, Reactogenicity, and Immunogenicity in Relation to the Product Attributes of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Adults ≥50 to <65 Years of Age

Randomized Adaptive Study for Safety and Efficacy of IMM01-STEM on Muscle Performance in Seniors with Sarcopenic Obesity.